# Zoetis Inc.  Share Price Target ‘$202.58’, now 18.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/zoetis-inc-share-price-target-202-58-now-18-8-upside-potential/4121188119
- Published: 2025-03-05T11:38:07+00:00
- Author: Charlotte Edwards

**Zoetis Inc.** with ticker code (ZTS) now have 17 analysts in total covering the
stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges
between $244.00 and $171.00 and has a mean share price target at $202.58. (at the
time of writing). Given that the stocks previous close was at $170.53 and the analysts
are correct then there would likely be a percentage uptick in value of 18.8%. Also
worth taking note is the 50 day moving average now sits at $166.70 while the 200
day moving average is $177.22. The company has a market capitalization of 76.08B.
The stock price is currently at: $169.90 USD

 The potential market cap would be $90,376,999,733 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 31.17, revenue per share of $20.38
and a 14.87% return on assets.

Zoetis Inc. is an animal health company. The Company is focused on the discovery,
development, manufacture and commercialization of medicines, vaccines, diagnostic
products and services, biodevices, genetic tests and precision animal health technology.
It commercializes products across eight core species: dogs, cats and horses and 
cattle, swine, poultry, fish and sheep and within product categories, such as vaccines,
anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated
feed additives and animal health diagnostics. The Company operates through two segments:
the United States and International. Within each of these operating segments, it
offers a product portfolio for both companion animal and livestock customers. The
Company market its products in approximately 45 countries across North America, 
Europe, Africa, Asia, Australia and South America. The Company’s products are sold
in more than 100 countries.

Share on:
